TacSense key facts
as of Oct 2026- Developer of sensitive pressure sensing interfaces designed to address global demands on the medical, consumer, robotic and automobile applications.
- TacSense is valued at approximately $57.4M as of Oct 2026 (last reported valuation).
- It has raised $23.7M; the latest was Later Stage VC ($3.5M) in Oct 2025.
- Notable investors include Plug and Play Tech Center, US National Science Foundation, Cowin Capital, Lenovo Capital and Incubator Group, Shenzhen CDF Capital — 13 tracked in total.
- Status: Privately Held (backing).
TacSense's last reported valuation, Oct 2025. Nothing priced has surfaced since.
- ·The complete investor list: 13 names
- ·Watch TacSense: the Monday email on marks, rounds and moves
TacSense funding rounds
No funding rounds for TacSense are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs TacSense
13+Membership and data by Private Market View
TacSense valuation
TacSense's last reported valuation was $57.4 million in Oct 2025. No priced round, secondary trade or fund mark has surfaced since.
TacSense investors
13 investors are on record for TacSense, including Plug and Play Tech Center, US National Science Foundation, Cowin Capital and Lenovo Capital and Incubator Group.
About TacSense
Developer of sensitive pressure sensing interfaces designed to address global demands on the medical, consumer, robotic and automobile applications. The company offers proprietary ionic materials to establish an ionic-electronic interface in response to mechanical stimuli and can provide noise-immune pressure signals in a mechanically flexible, optically transparent and ultra-thin package, thereby enabling users to use this sensor in various applications.
- Sector
- Business Products and Services (B2B)
- HQ
- Shenzhen, China
- Founded
- 2013
- Employees
- 26
- Website
- tacsense.cn/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.